降压药减停在退伍军人长期护理机构住民中的功能状态影响:有无痴呆的对比
该研究在12238名65岁以上退伍军人长期护理机构住民中模拟目标试验,比较降压药减停与继续使用对ADL依赖的影响。结果显示减停未对整体功能状态造成有害影响,在非痴呆亚组中减停者ADL略有改善而继续使用者下降,痴呆亚组无差异。
要点
- 长期护理住民中降压药减停未导致ADL功能恶化。
- 非痴呆亚组减停者ADL略有改善,继续使用者下降。
- 痴呆亚组中减停与ADL变化无显著关联。
核心结论
- 在长期护理机构住民中,无论有无痴呆,降压药减停对功能状态均无有害影响。
研究设计与样本
- 模拟目标试验,纳入12238名65岁以上退伍军人长期护理机构住民,2006至2019年间停留≥12周。
- 稳定使用降压药≥4周后分为减停组(减少≥1种药物或≥30%剂量)与继续使用组,随访2年。
- 主要采用逆概率治疗和删失加权的线性混合效应模型估计符合方案效应,并按痴呆状态分层。
主要发现
- 整体队列ADL评分每3个月平均恶化0.29分(95%CI=0.27,0.31),减停组与继续组间差异为每3个月-0.04分(95%CI=-0.15,0.06)。
- 非痴呆亚组ADL每3个月恶化0.15分(95%CI=0.11,0.19),但减停组ADL随时间略有改善而继续组下降,组间差异为每3个月-0.23分(95%CI=-0.43,-0.03)。
- 痴呆亚组中减停与ADL变化无显著关联。
- 意向性治疗分析结果与符合方案分析无实质性差异。
关键数值与推荐
- ADL依赖评分范围0-28分,分数越高功能越差,约每3个月评估一次。
- 减停定义:减少≥1种降压药或≥30%剂量。
临床怎么用
- 在长期护理机构中考虑减停降压药时,医生可参考该结果,减停未显示对功能状态有害。
- 对非痴呆住民,减停可能与ADL轻度改善相关,但需结合个体情况判断。
局限性
- 观察性模拟目标试验设计,可能存在残余混杂。
- 结果主要来自退伍军人长期护理人群,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deprescribing antihypertensives is of growing interest in geriatric medicine, yet the impact on functional status is unknown. We emulated a target trial of deprescribing antihypertensive medications compared with continued use on functional status measured by activities of daily living (ADL) in a long-term care population. METHODS: We included 12,238 Veteran Affairs long-term care residents age 65+ who had a stay ≥ 12 weeks between 2006 and 2019. After 4+ weeks of stable antihypertensive medication use, residents were classified as either deprescribed antihypertensives (reduced ≥ 1 medication or ≥ 30% dose) or continued users. Residents were followed up for 2 years, or censored at discharge, admission to hospice, protocol deviation (per-protocol analysis only), or Sept 30, 2019. The outcome was ADL dependencies (scored 0-28; higher score = worse functionality), assessed approximately every 3 months. Our primary approach was to estimate per-protocol effects using linear mixed-effects regressions with inverse probability of treatment and censoring weighting, overall and stratified by dementia status. We estimated intention-to-treat effects as a secondary analysis. RESULTS: In long-term care residents, ADL scores worsened by a mean of 0.29 points (95%CI = 0.27, 0.31) per 3 months and antihypertensive deprescribing did not impact this worsening (difference between groups -0.04 points every 3 months, 95%CI = -0.15, 0.06). In the non-dementia subgroup, ADL worsened by 0.15 points (95%CI = 0.11, 0.19) every 3 months. However, residents who were deprescribed showed a slightly improved ADL score over time while the continued users showed ADL decline (difference between groups -0.23 points every 3 months, 95%CI = -0.43, -0.03). Deprescribing was not associated with ADL change in the dementia subgroup. The intention-to-treat results were not meaningfully different. CONCLUSIONS: Antihypertensive deprescribing did not have a deleterious effect on functional status in long-term care residents with or without dementia. This may be reassuring to residents and clinicians who are considering antihypertensive medication reduction or discontinuation in long-term care settings.
引用
- Liu X, Graham LA, Jing B, et al. Antihypertensive Deprescribing and Functional Status in VA Long-Term Care Residents With and Without Dementia. J Am Geriatr Soc. 2025. PMID: 39750005. doi:10.1111/jgs.19342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。